Article Text

Download PDFPDF

Nerve agents: emergency preparedness
Free
  1. Alan George Andrew Weir1,2,
  2. S Makin2 and
  3. J Breeze3,4
  1. 1 Emergency Department, Basingstoke and North Hampshire Hospital, Basingstoke, UK
  2. 2 Army Medical Services, Camberley, UK
  3. 3 Royal Centre for Defence Medicine, Birmingham, UK
  4. 4 Department of Maxillofacial Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK
  1. Correspondence to J Breeze, Royal Centre for Defence Medicine, Birmingham B15 2SQ, UK; editor.bmjmilitary{at}bmj.com

Abstract

Nerve agents (NAs) are a highly toxic group of chemical warfare agents. NAs are organophosphorus esters with varying physical and chemical properties depending on the individual agent. The most recently developed class of NA is Novichok , the existence of which was first revealed in the early 1990s, just before Russia signed the Chemical Weapons Convention. In 1984, Iraq became the first nation to deploy NA on the battlefield when they used tabun against Iranian military forces in Majnoon Island near Basra. The first terrorist use of an NA is believed to be the attack in Matsumoto, Japan, on 27 June 1994 by the Aum Shinrikyo doomsday cult. Symptoms and ultimate toxicity from NA poisoning are related to the agent involved, the form and degree of exposure, and rapidity of medical treatment. The classic toxidrome of significant exposure to NA comprises bronchorrhoea, bronchospasm, bradycardia and convulsions, with an onset period of as early as a few seconds depending on the mode and extent of exposure. If medical management is not instituted rapidly, death may occur in minutes by asphyxiation and cardiac arrest. In the UK, emergency preparedness for NA poisoning includes an initial operational response programme across all blue light emergency services and key first responders. This paper describes the development, pathophysiology, clinical effects and current guidance for management of suspected NA poisoning. It also summarises the known events in which NA poisoning has been confirmed.

  • medical history
  • neurology
  • accident & emergency medicine

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors contributed to the conception, research and writing of the manuscript. All authors have approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

  • Data availability statement No data are available.